Manuel Antonio Espinoza (Manuel Espinoza, Manuel A Espinoza)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Venues

Methods and protocols

Revista de saude publica

BMC palliative care

Orphanet journal of rare diseases

Pontificia Universidad Catolica de Chile

University of York (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pontificia Universidad Catolica de Chile Aug 01 2008

Chile

Associate Professor :: Salud Pública

Education History

University of York

United Kingdom

PHD :: Economics

Publications

Ursula Giedion, Manuel Antonio Espinoza, Pamela Góngora-Salazar, Abha Mehndiratta, Dan Ollendorff
Harnessing Health Technology Assessment in Latin America and the Caribbean: Keeping the Region on Course. Health systems and reform 9 (3) (2024)
Hugo Ossandon, Nicolás Armijo, Constanza Vargas, Gabriela M Repetto, Manuel Antonio Espinoza
Challenges for gene therapy in the financial sustainability of health systems: a scoping review. Orphanet journal of rare diseases 19 (1) (2024)
Felipe Martínez, Carla Taramasco, Manuel Antonio Espinoza, Johanna Acevedo, Carolina Goic, Bruno Nervi
Effects on Quality of Life of a Telemonitoring Platform amongst Patients with Cancer (EQUALITE): A Randomized Trial Protocol. Methods and protocols 7 (2) (2024)
Felipe Martínez, Carla Taramasco, Manuel Antonio Espinoza, Johanna Acevedo, Carolina Goic, Bruno Nervi
Effects on Quality of Life of a Telemonitoring Platform amongst Patients with Cancer (EQUALITE): A Randomized Trial Protocol. Methods and protocols 7 (2) (2024)
Hugo Ossandon, Nicolás Armijo, Constanza Vargas, Gabriela M Repetto, Manuel Antonio Espinoza
Challenges for gene therapy in the financial sustainability of health systems: a scoping review. Orphanet journal of rare diseases 19 (1) (2024)
Felipe Martínez, Carla Taramasco, Manuel Antonio Espinoza, Johanna Acevedo, Carolina Goic, Bruno Nervi
Effects on Quality of Life of a Telemonitoring Platform amongst Patients with Cancer (EQUALITE): A Randomized Trial Protocol. Methods and protocols 7 (2) (2024)
Hugo Ossandon, Nicolás Armijo, Constanza Vargas, Gabriela M Repetto, Manuel Antonio Espinoza
Challenges for gene therapy in the financial sustainability of health systems: a scoping review. Orphanet journal of rare diseases 19 (1) (2024)
Marcela Oyarte, Baltica Cabieses, Manuel Antonio Espinoza, María Teresa Valenzuela, Iris Delgado
Perception of discrimination against immigrants compared to Chilean-born and its relationship with access to services and health outcomes. Revista de saude publica 56 (2023)
Sebastián García Martí, Andrés Pichón-Riviere, Federico Augustovski, Manuel Antonio Espinoza
Real-world evidence: experiences and challenges for decision making in Latin America. International journal of technology assessment in health care 39 (1) (2023)
Nicolás Armijo, Tomás Abbot, Manuel Antonio Espinoza, Ximena Neculhueque, Carlos Balmaceda
Estimation of the demand for palliative care in non-oncologic patients in Chile. BMC palliative care 22 (1) (2023)
Marcela Oyarte, Baltica Cabieses, Manuel Antonio Espinoza, María Teresa Valenzuela, Iris Delgado
Perception of discrimination against immigrants compared to Chilean-born and its relationship with access to services and health outcomes. Revista de saude publica 56 (2023)
Sebastián García Martí, Andrés Pichón-Riviere, Federico Augustovski, Manuel Antonio Espinoza
Real-world evidence: experiences and challenges for decision making in Latin America. International journal of technology assessment in health care 39 (1) (2023)
Nicolás Armijo, Tomás Abbot, Manuel Antonio Espinoza, Ximena Neculhueque, Carlos Balmaceda
Estimation of the demand for palliative care in non-oncologic patients in Chile. BMC palliative care 22 (1) (2023)
Nicolás Armijo, Tomás Abbot, Manuel Antonio Espinoza, Ximena Neculhueque, Carlos Balmaceda
Estimation of the demand for palliative care in non-oncologic patients in Chile. BMC palliative care 22 (1) (2023)
Marcela Oyarte, Baltica Cabieses, Manuel Antonio Espinoza, María Teresa Valenzuela, Iris Delgado
Perception of discrimination against immigrants compared to Chilean-born and its relationship with access to services and health outcomes. Revista de saude publica 56 (2023)
Carlos Balmaceda, Paulina Muñoz, Manuel Antonio Espinoza, Alvaro Tellez, Teresita Varela, Francisco Suarez, Maria Jose Fernandez
Impact of a high-risk multimorbidity integrated care implemented at the public health system in Chile. PloS one 17 (1) (2022)
Manuel Antonio Espinoza, Norberto Bilbeny, Tomas Abbott, Cesar Carcamo, Pedro Zitko, Paula Zamorano, Carlos Balmaceda
Cost analysis of chronic pain due to musculoskeletal disorders in Chile. PloS one 17 (10) (2022)
Carlos Balmaceda, Manuel Antonio Espinoza, Tomas Abbott, Anne Peters
Cost-effectiveness analysis: fluticasone furoate/umeclidinium/vilanterol for the treatment of moderate to severe chronic obstructive pulmonary disease from the perspective of the Chilean public health system. Expert review of pharmacoeconomics & outcomes research 22 (5) (2022)
Manuel Antonio Espinoza, Tomas Abbott, Alvaro Passi, Carlos Balmaceda
Health and economic effects on patients with type 2 diabetes mellitus in the long run: predictions for the Chilean population. Diabetology & metabolic syndrome 14 (1) (2022)
Maria Elvira Balcells, Luis Rojas, Nicole Le Corre, Constanza Martínez-Valdebenito, Maria Elena Ceballos, Marcela Ferrés, Mayling Chang, Cecilia Vizcaya, Sebastián Mondaca, Alvaro Huete, Ricardo Castro, Mauricio Sarmiento Maldonado, Luis Villarroel, Alejandra Pizarro, Patricio Ross, Jaime Santander, Bárbara Lara, Marcela Ferrada, Sergio Vargas-Salas, Carolina Beltrán-Pavez, Ricardo Soto-Rifo, Fernando Valiente-Echeverría, Christian Caglevic, Mauricio Mahave, Carolina Selman, Raimundo Gazitúa, José Luis Briones, Franz Villarroel-Espindola, Carlos Balmaceda, Manuel Antonio Espinoza, Jaime Pereira, Bruno Nervi
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial. PLoS medicine 18 (3) (2021)
Pedro Zitko, Norberto Bilbeny, Carlos Balmaceda, Tomas Abbott, Cesar Carcamo, Manuel Antonio Espinoza
Prevalence, burden of disease, and lost in health state utilities attributable to chronic musculoskeletal disorders and pain in Chile. BMC public health 21 (1) (2021)
Manuel Antonio Espinoza, Rubén Rojas, Alessandro Zaupa, Carlos Balmaceda
A Model-Based Economic Evaluation of Cladribine Versus Alemtuzumab, Ocrelizumab and Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in Chile. PharmacoEconomics - open 5 (4) (2021)
Manuel Antonio Espinoza, Andrea Manca, Karl Claxton, Mark Sculpher
Social value and individual choice: The value of a choice-based decision-making process in a collectively funded health system. Health economics 27 (2) (2017)

Manuel Antonio Espinoza.css-eqlu8i{font-size:small;padding-left:4px;} (Manuel Espinoza, Manuel A Espinoza)

Publication Activity (10 Years)

Top Topics

Top Venues

Manuel Antonio Espinoza (Manuel Espinoza, Manuel A Espinoza)